In 2023, the mortality rate for liver malignant neoplasms in the UK stood at 11.7 per hundred thousand men. The forecasted data for 2024 to 2028 shows a gradual year-on-year increase in mortality rates, with an annual increase of about 0.2 deaths per hundred thousand men. Specifically, from 2024 to 2027, the rates are expected to rise from 11.9 to 12.3, culminating at 12.4 in 2028. This reflects a consistent annual growth rate of approximately 1% to 1.7% year-on-year and highlights a Compound Annual Growth Rate (CAGR) of 1.2% over the five-year forecasting period.
Future trends to watch for include advancements in medical research and treatment options, public health initiatives to reduce risk factors such as alcohol consumption and viral hepatitis, and socio-economic factors potentially influencing healthcare access and outcomes. Monitoring these elements will be crucial in assessing and potentially mitigating this upward trend in mortality rates.
